CompoAtlas

Estroclear phase 2

Natural health product licensed in Canada

Other names
Asportek Estroclear phase 2
Licence holder
Asportek
NPN or DIN-HM
80071956
Status
Active licence
Licence date
11 August 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Camellia sinensis

Source : Feuille

Potency : 98 % Poly(phénols)

100 milligrammeNot calculated
D-saccharate de calcium

Source : Saccharate de calcium

200 milligrammeNot calculated
Curcuma longa

Source : Rhizome

Extraction ratio : 25:1

Dry plant equivalent : 4,000 milligramme

Potency : 70 % Curcumine

160 milligrammeNot calculated
3,3'-diindolylméthane

Source : 3,3'-diindolylméthane

200 milligrammeNot calculated
Brassica oleracea var. italica

Source : Graine(s)

Potency : 10 % Glucoraphanine

100 milligrammeNot calculated
Camellia sinensis

Source : Feuille

Potency : 80 % Catéchines

Not specifiedNot calculated
trans-Resvératrol

Source : Reynoutria Japonica - racine

100 milligrammeNot calculated
3-hydroxyméthylindole

Source : Indole-3-carbinol

100 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, L-Leucine

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Fournit des antioxydants qui aident à combattre les dommages cellulaires causés par les radicaux libres. Le DIM et l'Indole-3-Carbinole aident à promouvoir un équilibre sain d'oestrogènes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80071956

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line